Two Sigma Advisers’s Kura Oncology KURA Stock Holding History

Two Sigma Advisers’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.55M	Buy	442,500 +163,900	+59%	+$946K	0.01%	1003
2025 Q1	$1.84M	Buy	278,600 +36,400	+15%	+$240K	﹤0.01%	1190
2024 Q4	$2.11M	Buy	242,200 +144,201	+147%	+$1.26M	﹤0.01%	1099
2024 Q3	$1.91M	Sell	97,999 -16,701	-15%	-$326K	﹤0.01%	1088
2024 Q2	$2.36M	Buy	114,700 +28,200	+33%	+$581K	0.01%	1102
2024 Q1	$1.85M	Buy	86,500 +64,900	+300%	+$1.38M	﹤0.01%	1271
2023 Q4	$311K	Sell	21,600 -2,300	-10%	-$33.1K	﹤0.01%	2091
2023 Q3	$218K	Buy	23,900 +3,700	+18%	+$33.7K	﹤0.01%	2078
2023 Q2	$214K	Sell	20,200 -23,200	-53%	-$245K	﹤0.01%	2081
2023 Q1	$531K	Sell	43,400 -151,900	-78%	-$1.86M	﹤0.01%	1923
2022 Q4	$2.42M	Sell	195,300 -171,700	-47%	-$2.13M	0.01%	1131
2022 Q3	$5.01M	Buy	367,000 +116,100	+46%	+$1.59M	0.01%	730
2022 Q2	$4.6M	Sell	250,900 -16,200	-6%	-$297K	0.01%	813
2022 Q1	$4.3M	Sell	267,100 -157,700	-37%	-$2.54M	0.01%	867
2021 Q4	$5.95M	Sell	424,800 -162,900	-28%	-$2.28M	0.01%	691
2021 Q3	$11M	Sell	587,700 -111,000	-16%	-$2.08M	0.03%	485
2021 Q2	$14.6M	Buy	698,700 +65,300	+10%	+$1.36M	0.04%	425
2021 Q1	$17.9M	Buy	633,400 +137,000	+28%	+$3.87M	0.05%	389
2020 Q4	$16.2M	Buy	496,400 +320,900	+183%	+$10.5M	0.04%	403
2020 Q3	$5.38M	Sell	175,500 -73,600	-30%	-$2.25M	0.02%	740
2020 Q2	$4.06M	Buy	249,100 +7,100	+3%	+$116K	0.01%	887
2020 Q1	$2.41M	Buy	242,000 +107,500	+80%	+$1.07M	0.01%	1013
2019 Q4	$1.85M	Buy	134,500 +84,100	+167%	+$1.16M	﹤0.01%	1266
2019 Q3	$765K	Buy	50,400 +13,200	+35%	+$200K	﹤0.01%	1548
2019 Q2	$732K	Buy	37,200 +18,600	+100%	+$366K	﹤0.01%	1661
2019 Q1	$309K	Buy	18,600 +4,300	+30%	+$71.4K	﹤0.01%	1975
2018 Q4	$201K	Buy	14,300 +300	+2%	+$4.22K	﹤0.01%	2132
2018 Q3	$245K	Sell	14,000 -3,800	-21%	-$66.5K	﹤0.01%	2019
2018 Q2	$324K	Buy	+17,800	New	+$324K	﹤0.01%	2075